SEC Form 4 · accession 0001179110-16-027682
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason N Gorevic
Officer — President & CEO · Director
Period of report
Jul 15, 2016
Accepted (ET)
Jul 15, 2016 · 6:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2016 | M | 5,000 | $1.07 | A | 932,258 | D | |
| Common StockF2 | Jul 15, 2016 | S | 5,000 | $15.45 | D | 927,258 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.07 | Jul 15, 2016 | M | 5,000 | D | Apr 16, 2013 | Apr 16, 2022 | Common Stock | 5,000 | 285,027 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2016.
- F2Represents the weighted average price of transactions ranging from $15.41 to $15.50. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.